
News|Articles|November 2, 2004
- Pharmaceutical Technology-11-02-2004
- Volume 28
- Issue 11
FDA Moves To Implement New GMP Policies
Author(s)Jill Wechsler
Phase II of FDA's GMP modernization plan may involve revising regulations to fit new policies and inspection and review programs.
Advertisement
Articles in this issue
over 21 years ago
Still Waiting for Answersover 21 years ago
Comparing and Contrasting Barrier Isolator Decontamination Systemsover 21 years ago
November 2004over 21 years ago
In the Spotlight-November 2004over 21 years ago
Searching for a Viable Business ModelNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Bristol Myers Squibb and Johnson & Johnson Launch Educational Program for Thromboembolic R&D
2
FDA Grants Priority Review to AZ's Datroway for Metastatic Triple Negative Breast Cancer
3
Behind the Headlines Episode 32: AI’s Power, NVIDIA & Lilly, Revolution Medicine
4
Women Leading Biotech: Advancing Treatments for Ovarian Cancer
5




